164 related articles for article (PubMed ID: 29927230)
1. Prevalence of Chronic Hepatitis B Infection in Patients with Systemic Lupus Erythematosus: Viral Reactivation and Impact on Disease Activity.
Sumethkul K; Srivitidkul S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S124-30. PubMed ID: 29927230
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of methotrexate does not result in hepatitis B reactivation in rheumatologic patients.
Laohapand C; Arromdee E; Tanwandee T
Hepatol Int; 2015 Apr; 9(2):202-8. PubMed ID: 25788188
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.
Lu CL; Tsai ST; Chan CY; Hwang SJ; Tsai CY; Wu JC; Lu RH; Lin BC; Lee SD
J Gastroenterol Hepatol; 1997 Apr; 12(4):272-6. PubMed ID: 9195365
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Screening for Hepatitis B Virus Infection in Patients with Systemic Lupus Erythematosus.
Watanabe R; Ishii T; Harigae H
Tohoku J Exp Med; 2015 Sep; 237(1):9-15. PubMed ID: 26288957
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Hepatitis B Markers in Systemic Lupus Erythematosus Patients in Iran.
Makvandi M; Noormandi Pour S; Teimoori A; Shokri S; Mahmoudvand S; Biparva Haghighi S; Rajaee E
Asian Pac J Cancer Prev; 2022 Jun; 23(6):1921-1926. PubMed ID: 35763632
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.
Watanabe R; Ishii T; Nakamura K; Shirai T; Tajima Y; Fujii H; Harigae H
Mod Rheumatol; 2013 Nov; 23(6):1094-100. PubMed ID: 23180323
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey.
Watanabe R; Ishii T; Kobayashi H; Asahina I; Takemori H; Izumiyama T; Oguchi Y; Urata Y; Nishimaki T; Chiba K; Komatsuda A; Chiba N; Miyata M; Takagi M; Kawamura O; Kanno T; Hirabayashi Y; Konta T; Ninomiya Y; Abe Y; Murata Y; Saito Y; Ohira H; Harigae H; Sasaki T
Tohoku J Exp Med; 2014 Jun; 233(2):129-33. PubMed ID: 24898712
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice.
Nunes J; Marinho RT; Fonseca JE; Pereira da Silva JA; Velosa J
Acta Reumatol Port; 2011; 36(2):110-8. PubMed ID: 21841730
[TBL] [Abstract][Full Text] [Related]
10. High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus.
Chen MH; Wu CS; Chen MH; Tsai CY; Lee FY; Huang YH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502025
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus.
Lo Presti A; Ceccarelli F; Dorrucci M; Farchi F; Pirone C; Garufi C; Valdarchi C; Spinelli FR; Alessandri C; Chionne P; Madonna E; Pisani G; Martina A; Simeoni M; Bruni R; Ciccozzi M; Iaiani G; Ciccaglione AR; Spada E; Conti F
New Microbiol; 2022 Dec; 45(4):296-303. PubMed ID: 36538293
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients.
Chen X; Hong L; Zhang W; Yuan M; Yang Q; Mao H; Chen W; Yu X
Med Sci Monit; 2015 Jul; 21():1955-9. PubMed ID: 26148056
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China.
Zhao J; Qiu M; Li M; Lu C; Gu J
Rheumatol Int; 2010 Nov; 30(12):1565-70. PubMed ID: 19826817
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection in patients with systemic lupus erythematosus.
Chng HH; Fock KM; Chew CN; Guan R; Feng PH; Boey ML; Chee EN; Chua KL
Singapore Med J; 1993 Aug; 34(4):325-6. PubMed ID: 8266204
[TBL] [Abstract][Full Text] [Related]
17. Management of psoriasis patients with hepatitis B or hepatitis C virus infection.
Bonifati C; Lora V; Graceffa D; Nosotti L
World J Gastroenterol; 2016 Jul; 22(28):6444-55. PubMed ID: 27605880
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in patients with resolved hepatitis B virus infection receiving chemotherapy or immunosuppressive therapy.
Su YC; Lin PC; Yu HC; Wu CC
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):925-929. PubMed ID: 29621049
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
20. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.
Patel A; Yapali S; Lok AS
Hepatol Int; 2016 Jan; 10(1):139-46. PubMed ID: 26272106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
